Cited by 51Meta-analysis and systematic reviewsPharmaceutical industry and healthcareStatistical Methods in Clinical Trials

Are randomized trials conducted in China or India biased? A comparative empirical analysis

Zhang, Dalu, Freemantle, Nick, Cheng, K.K.·2011·Journal of Clinical Epidemiology

Abstract

Context China and India are two emerging forces in undertaking randomized clinical trials. The quality of trials from these countries may affect not just their substantial populations but also their contribution to health policy throughout the world.Objective The objectives of this study were to describe and contrast the quality and biases in reports of trials conducted in China and India with a set of "gold standard" trials reported in leading European and North American journals.Method A systematic review and comparative empirical analysis of randomized controlled trial reports published in selected Chinese, Indian, and European or North American medical journals were performed. Quality was assessed against a subset of criteria from the CONSORT statement. We compared the rate of reporting of positive outcomes in clinical trials to describe potential bias.Result In total, 307 Chinese papers, 117 Indian papers, and 304 Western papers were included. Reports of Indian trials were slightly better than Chinese papers on the trial reporting quality indicators and much better than Chinese papers on reporting patients' ethical issues. However, the gold standard Western trial reports scored considerably higher on all quality criteria. Chinese papers were substantially more likely to report statistically significant results (odds ratio [OR]=2.96, 95% confidence interval [CI]=2.23-3.94; P<0.0001). Indian trials reported a similar rate of positive results to Western papers (OR=0.92, 95% CI=0.69-1.24; P=0.59).Conclusion Reporting of trials in major Chinese and Indian journals falls short of that achieved in the gold standard Western journals we appraised and may reflect underlying inadequacies in the design and conduct of these trials. Chinese trials appear biased and may selectively report positive outcomes while ignoring neutral or negative outcomes. Trialists and journal editors in China and India should adopt the CONSORT reporting guidelines, should ensure that a primary outcome is prespecified and reported, and should ensure that analysis is conducted according to the intention-to-treat principle. Ethical questions in the conduct of trials in China must be addressed.

Integrity signals

Registry

Crossref · 10.1016/j.jclinepi.2010.02.010

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, D., Freemantle, N., & Cheng, K. K.
Affiliations
University of Birmingham (GB)
Corresponding author
Freemantle, Nick
Venue
Journal of Clinical Epidemiology
Publisher
Elsevier BV
Published
2011-01
Volume
64
Issue
1
Pages
90-95
ISSN
0895-4356 (ISSN-L)
OpenAlex
W2079967028
Cited by
51
References
12
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 3 · 2013: 6 · 2012: 6
FWCI
5.29
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
randomized controlled trials, trial reporting quality, reporting bias, selective outcome reporting, CONSORT statement, China, India, intention-to-treat analysis
MeSH terms
China, Europe, Humans, India, Periodicals as Topic, Reference Standards, Randomized Controlled Trials as Topic, Publication Bias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review